在PROTAC设计,开发和合成中使用FDA批准的激酶抑制剂
Kacper Kossakowski1,2, Alina Cherniienko1,2, Lucjusz Zaprutko1
1Department and Chair of Organic Chemistry, Poznan University of Medical Sciences, Poznan, Poland.
Journal of enzyme inhibition and medicinal chemistry
|August 12, 2025
概括
化向基马体 (PROTACs) 通过降解化酶,克服酶抑制剂常见的耐药性和非向效应,为癌症治疗提供了一种新方法. 本综述探讨了PROTAC的设计和开发,用于下一代酶向治疗.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 美国食品和药物管理局批准的激酶抑制剂在瘤学中至关重要,但面临着耐药性和非目标效应等挑战.
- 化向化学酶 (PROTACs) 降解向蛋白质,为传统抑制剂提供了替代品.
研究的目的:
- 为使用FDA批准的激酶抑制剂设计的PROTACs提供全面的概述.
- 讨论用于酶向PROTACs的合理设计,开发和合成策略.
主要方法:
- 对 PROTACs 的合理设计原则的审查.
- 对PROTAC开发的综合方法的分析.
- 讨论影响降解器效率的因素.
主要成果:
- 与酶抑制剂相比,PROTACs提供了增强的选择性和抗药性降低.
- 对于PROTAC效率的关键因素包括酶选择性,链接器设计和E3酶招募.
结论:
- 在酶驱动疾病中,PROTAC技术对下一代疗法具有前景.
- 持续的PROTAC进化需要优化链接器化学和扩大E3结合酶多样性.
相关概念视频
02:54Protein Kinases and Phosphatases
13.4K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.4K
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K